• Propanc Biopharma will implement a 1-for-10 reverse stock split to restore compliance with Nasdaq’s $1.00 minimum bid price requirement.
• The announcement lists conflicting effective dates: market open October 26, 2026, and before market open October 19, 2026.
• Every 10 outstanding common shares will become one share, with fractional shares rounded up to the nearest whole share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Propanc Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610220830PRIMZONEFULLFEED9851108) on October 22, 2026, and is solely responsible for the information contained therein.